GCG and Hypoglycemia: Indeed, while insulin effectively controls hyperglycemia,it can also increase the risk of cardiovascular events by causing hypoglycemia.In contrast, modern therapies such as glucagon-like peptide-1 (GLP-1) receptoragonists and sodium–glucose co-transporter 2 (SGLT2) inhibitors aid inregulating blood sugar and offer additional cardiovascular benefits [9, 10, 11],including reduced blood pressure, ameliorated inflammation, and improved lipidprofiles.